Table of Contents
젤라틴 캡슐의 역사:
젤라틴 캡슐은 수세기를 거슬러 올라가는 길고 흥미로운 역사를 가지고 있습니다. 제약 및 기능식품 산업에서 일반적으로 사용되는 이 캡슐은 고유한 특성과 다용성으로 인해 다양한 물질을 캡슐화하는 데 널리 사용됩니다. 이 기사에서는 젤라틴 캡슐의 기원과 진화를 탐구하여 시간에 따른 흥미로운 여정을 조명합니다.
젤라틴 캡슐의 역사는 천연 재료를 사용하여 의약품과 치료제를 캡슐화했던 고대 문명으로 거슬러 올라갑니다. . 예를 들어, 중국에서는 젤라틴 캡슐의 사용이 당나라(618-907 AD)까지 거슬러 올라갈 수 있다고 믿어집니다. 이 기간 동안 중국인은 생선, 돼지고기 등 동물성 원료에서 추출한 젤라틴 물질을 사용하여 약초와 분말을 캡슐화했습니다.
그러나 오늘날 우리가 알고 있는 젤라틴 캡슐이 처음 소개된 것은 19세기가 되어서였습니다. . 1834년에 프랑스의 약사인 Fran\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\çois Mothes는 “젤라틴 진주”라고 불리는 최초의 젤라틴 캡슐을 발명했습니다. 이 캡슐은 유리 막대를 젤라틴 용액에 담그고 건조시켜 작고 속이 빈 껍질을 만들어 만들어졌습니다. Mothes의 발명은 편리하고 효율적인 약물 투여 방법을 제공하여 제약 산업에 혁명을 일으켰습니다.
수년에 걸쳐 기술 및 제조 공정의 발전으로 젤라틴 캡슐 생산이 크게 향상되었습니다. 20세기 초, 회전식 다이 기계가 도입되면서 젤라틴 캡슐 제조 공정이 더욱 개선되었습니다. 이 기계를 통해 캡슐의 대량 생산이 가능해졌고, 이를 통해 캡슐을 더 널리 보급하고 저렴하게 만들 수 있었습니다.
| 미생물 지표 | ||||
| 프로젝트 | 단위 | 지표 요구사항 | 시험 결과 | |
| 총 콜로니 수 | CFU/g | \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\≤1000 | 500 | |
| 살모넬라균 | /25g | 체크아웃하면 안 됩니다 | 체크아웃되지 않음 | |
| 대장균군 | MPN/g | \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\ \\\\\\\\\\\\\\\\\\\\\≤3 | <1 | |
| 출처 | 안전 비감염지역 | |||
| 점검 결론 | 적격 | |||
1960년대 제약산업은 2피스 젤라틴 캡슐의 개발로 캡슐 기술의 또 다른 혁신을 목격했습니다. 이전에는 젤라틴 캡슐을 수동으로 채우는 것이 일반적이었고 이는 시간이 많이 걸리고 노동 집약적인 과정이었습니다. 쉽게 장착할 수 있는 본체와 캡으로 구성된 2피스 디자인은 캡슐 충전에 혁명을 일으켜 자동화된 생산과 효율성 향상을 가능하게 했습니다.
최근 몇 년 동안 젤라틴 캡슐은 채식 캡슐과 같은 대체 재료와의 경쟁에 직면해 있습니다. 셀룰로오스나 전분으로 만든 캡슐. 이러한 대안은 동물 유래 제품의 섭취를 금지하는 식이 제한이나 종교적 신념을 가진 개인에게 적합합니다. 그러나 젤라틴 캡슐은 독특한 특성으로 인해 계속해서 널리 사용되고 선호되고 있습니다.
이 캡슐의 주성분인 젤라틴은 동물의 결합 조직에서 발견되는 단백질인 콜라겐에서 추출됩니다. 생분해성이고 소화가 쉬우며 의약품, 식이보충제, 생약 추출물 등 다양한 물질과의 상용성이 뛰어난 천연 소재입니다.
결론적으로 젤라틴 캡슐은 수세기에 걸친 풍부한 역사를 가지고 있습니다. 고대 중국의 소박한 기원부터 현대 자동화까지
– 젤라틴 캡슐은 고대 시대까지 거슬러 올라가는 오랜 역사를 가지고 있습니다. 젤라틴을 캡슐화 재료로 사용한 것은 동물의 가죽과 뼈를 끓여서 젤라틴을 추출했던 이집트 문명까지 거슬러 올라갑니다. 이 젤라틴은 캡슐을 만드는 데 사용되었습니다.
젤라틴 캡슐은 고대까지 거슬러 올라가는 길고 흥미로운 역사를 가지고 있습니다. 캡슐화 재료로 젤라틴을 사용한 것은 동물의 가죽과 뼈를 끓여서 젤라틴을 추출했던 이집트 문명까지 거슬러 올라갑니다. 콜라겐에서 추출된 단백질인 이 젤라틴은 다양한 목적으로 캡슐을 만드는 데 사용되었습니다.
고대 이집트인은 캡슐화에 젤라틴을 사용하는 선구자였습니다. 그들은 젤라틴의 독특한 특성과 다양한 물질에 대한 보호 케이스를 만드는 능력을 발견했습니다. 동물의 가죽과 뼈를 끓여서 젤라틴을 추출할 수 있었고, 이를 다양한 크기와 모양의 캡슐로 만들 수 있었습니다.
이 초기 젤라틴 캡슐은 약용 및 요리 목적으로 사용되었습니다. 의학에서는 약초 추출물과 기타 치료법으로 채워져 치료를 관리하는 편리한 방법을 제공했습니다. 젤라틴 캡슐은 또한 요리 세계로 진출하여 풍미 있는 재료를 캡슐화하고 식용 별미를 만드는 데 사용되었습니다.
시간이 지남에 따라 젤라틴 캡슐의 사용은 그리스인과 로마인을 포함한 다른 문명으로 퍼졌습니다. 그들은 다양한 캡슐화 재료로서 젤라틴의 이점을 인식하고 이러한 캡슐을 만드는 기술을 더욱 개선했습니다. 젤라틴 캡슐을 만들기 위한 지식과 기술은 세대를 거쳐 전승되어 새로운 발견과 발전이 이루어지면서 진화했습니다.
현대 시대에 젤라틴 캡슐은 제약 및 기능 식품 산업에서 널리 사용됩니다. 이들의 인기는 다용도성, 사용 용이성 및 다양한 물질과의 호환성 때문일 수 있습니다. 젤라틴 캡슐은 다양한 크기로 제공되며 분말, 액체 또는 반고체로 충전할 수 있어 다양한 제품에 적합합니다.
젤라틴 캡슐의 생산은 엄격한 품질 관리 조치를 통해 더욱 정교해졌습니다. 안전성과 효능을 확보할 수 있는 곳입니다. 캡슐 생산에 사용되는 젤라틴은 엄격한 기준을 충족하도록 신중하게 공급 및 가공되어 신뢰할 수 있고 일관된 성능을 지닌 캡슐을 만듭니다.
결론적으로, 젤라틴 캡슐의 기원은 다음과 같은 고대 문명으로 거슬러 올라갈 수 있습니다. 캡슐화 재료로서의 젤라틴이 시작되었습니다. 시간이 지남에 따라 젤라틴 캡슐을 만드는 지식과 기술이 발전하여 현대 산업에서 널리 사용되었습니다. 오늘날 젤라틴 캡슐은 지속적인 유산과 유용성을 반영하여 의약품 및 기능 식품 캡슐화에 계속해서 인기 있는 선택입니다.